SUPN
Supernus Pharmaceuticals Inc
Price:  
27.77 
USD
Volume:  
623,542.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SUPN Intrinsic Value

%
Upside

As of 2024-05-24, the Intrinsic Value of Supernus Pharmaceuticals Inc (SUPN) is 2.60 USD. This SUPN valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 27.77 USD, the upside of Supernus Pharmaceuticals Inc is %.

The range of the Intrinsic Value is 2.22 - 3.17 USD

27.77 USD
Stock Price
2.60 USD
Intrinsic Value
Intrinsic Value Details

SUPN Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) (63.76) - (1.12) (3.21) -111.5%
DCF (Growth 10y) (1.11) - (55.53) (2.96) -110.7%
DCF (EBITDA 5y) 2.22 - 3.17 2.60 -90.6%
DCF (EBITDA 10y) 2.28 - 4.53 3.12 -88.8%
Fair Value -1.42 - -1.42 -1.42 -105.10%
P/E (3.09) - 2.19 (1.41) -105.1%
EV/EBITDA 1.19 - 23.76 11.14 -59.9%
EPV 22.79 - 47.14 34.97 25.9%
DDM - Stable (2.81) - (10.06) (6.43) -123.2%
DDM - Multi 2.90 - 8.20 4.30 -84.5%

SUPN Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 1,519.85
Beta 0.84
Outstanding shares (mil) 54.73
Enterprise Value (mil) 1,456.45
Market risk premium 4.60%
Cost of Equity 8.79%
Cost of Debt 10.35%
WACC 8.26%